SAN DIEGO, Oct. 16, 2012 /PRNewswire-USNewswire/ -- The following is being issued by the law firms of Beasley Allen, P.C., Gary Holt & Associates, P.A., and Rushall & McGeever:
Official notice to potential Class Members has begun in a class action lawsuit that claims that drug manufacturer Wyeth violated California laws by misrepresenting the benefits and/or failing to disclose the risks of the prescription hormone replacement therapy (HRT) medications Premarin, Prempro, and Premphase.
The United States District Court for the Southern District of California has certified the case as a class action. At this stage, no determination has been made as to which side is right and the case is proceeding to trial. Wyeth denies it did anything wrong and lawyers for the Class will have to prove their claims in Court.
California residents who purchased the drugs in California between January 1995 and January 2003 may be included in the lawsuit, if they were exposed to 1) oral or written statements from Wyeth or from a healthcare provider, or 2) written statements in publications in which Wyeth advertised or that originated from Wyeth, that:
- Premarin, Prempro, and/or Premphase lowered cardiovascular, Alzheimers, and/or dementia risk; or
- Premarin, Prempro, and/or Premphase did not increase breast cancer risk.
To be included in the Class, consumers must also not be claiming any personal injury from the use of Prempro, Premarin, and/or Premphase.
Class Members do not need to do anything to stay in the Class. However, Class Member rights will be affected if they do nothing. Class Members that do not want to be legally bound by what the Court does must exclude themselves from the case by December 19, 2012. Class Members that do not exclude themselves will not be able to sue for any claim relating to the lawsuit.
SOURCE Beasley Allen, P.C., Gary Holt & Associates, P.A., and Rushall & McGeever